Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cancer Research UK: Early Diagnosis And Disease Detection Must Not Be Eclipsed By COVID-19

Joined-up UK cancer diagnosis plan can be the blueprint for wider diagnostics strategy

Executive Summary

Coronavirus has diverted the focus of health systems away from early cancer detection, says a new report by Cancer Research UK, urging a rebalancing of priorities.

You may also be interested in...



UK Can Set The Pace In Ending Late Stage Disease Diagnosis, Says Cancer Charity

Earlier detection of cancer can only happen with a concerted, government led effort, more investment and cross industry collaboration, says CRUK. Its Roadmap to the Future sets out the milestones for achieving that aim.

MHRA’s Lee To Give UK Medtech Industry Greater Diagnostics Focus

The UK ABHI has created a new role for a director of diagnostics regulation, which MHRA IVD’s policy adviser Steve Lee will fill later this month.

The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’

The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142858

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel